browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
2d3e9049-0e96-4f08-87f4-a341471933ed
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 18:03:08
Income (reported)
$30,000
Expenses (reported)
—
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

INNOVATIVE FEDERAL STRATEGIES, LLC

government relations

Contact
WILLIAM TATUM
Phone
+1 202-347-5990
Address
zip:20002, city:Washington, state:DC, street:511 C Street NE
Client

ACURX PHARMACEUTICALS, INC.

biopharmaceutical company

State
NY
Country
US
Effective date
2024-11-01
Issues lobbied + lobbyists (1)

BUD — Budget/Appropriations

H.R.____/S.____, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, 2027, Title II, all provisions related research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.